Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment

INTRODUCTION: In recent years, immune checkpoint inhibitors (ICIs) have attracted widespread attention and made breakthroughs in progress towards the treatment of various cancers. However, ICI therapy is selective, and its effects on many patients are not ideal. It is therefore critical to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Anqi, Gu, Tianqi, Hu, Xigang, Zhang, Jian, Luo, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192307/
https://www.ncbi.nlm.nih.gov/pubmed/35707003
http://dx.doi.org/10.1155/2022/8179799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192307/
https://www.ncbi.nlm.nih.gov/pubmed/35707003
http://dx.doi.org/10.1155/2022/8179799

Ejemplares similares